Title here

Text here

MELANOMA RESEARCH ALLIANCE FOUNDATION

AKA Melanoma Research Alliance; MRA

Washington, DC

GuideStar Quick View Everything you need to know...

MELANOMA RESEARCH ALLIANCE FOUNDATION

Also Known As:
Melanoma Research Alliance; MRA
Physical Address:
Washington, DC 20005 
EIN:
26-1636099
Web URL:
www.CureMelanoma.org
Blog URL:
curemelanoma.wordpre...
Leadership:
Mrs. Wendy K.D. Selig
Detailed Financial and People Data included in the GuideStar Premium Report Report Added To Cart

Legitimacy Information

  • This organization is registered with the IRS.
  • This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.


Forms 990 from IRS Additional Information IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar Web site is an ongoing process.

Forms 990 for 2012, 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.

Annual Revenue & Expenses Additional Information Financial information on GuideStar is either digitized from Form 990 images we receive from the IRS or submitted by the nonprofits themselves through the GuideStar Exchange (990 filers cannot override Form 990 financial data). If your organization does not file a Form 990, 990-EZ, or 990-PF and you would like to have your financial data displayed in this section, join the GuideStar Exchange today!

Fiscal Year Starting: Jan 1, 2012
Fiscal Year Ending: Dec 31, 2012
Revenue
Total Revenue $8,692,431
Expenses
Total Expenses $9,337,447

Is this information up-to-date?
Claim your report and update your GuideStar Exchange profile today!

Financial data from Forms 990 for Year 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.



GuideStar Exchange Member

This organization is a Gold-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your organization's report?
Update your organization's information today!


Basic Organization Information

MELANOMA RESEARCH ALLIANCE FOUNDATION

Also Known As:
Melanoma Research Alliance; MRA
Physical Address:
Washington, DC 20005 
EIN:
26-1636099
Web URL:
www.CureMelanoma.org 
Blog URL:
curemelanoma.wordpre... 
NTEE Category:
H Medical Research 
H30 Cancer Research 
U Science and Technology Research Institutes 
U01 Alliance/Advocacy Organizations 
Year Founded:
2007 
Ruling Year:
2009 
How This Organization Is Funded:
Public
Co-Founders
Corporate Partnerships

Sign in or create an account to see this organization's full address, contact information, and more!


Mission Statement

The mission of the MRA is to accelerate the pace of scientific discovery and its translation into effective options for patients – in prevention, diagnosis, prognosis, and treatment – in order to eliminate suffering and death due to melanoma.

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.

Financial Data

Sign in or create an account to view Revenue and Expense data for the most recent fiscal year.


Revenue and Expenses

Sign in or create an account to view this information for the most recent fiscal year.

Revenue and Expense data from Forms 990 for 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Balance Sheet

Balance Sheet data from Forms 990 for Year 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

A multi-year analysis of key balance sheet, income statement, profitability and liquidity measures is available for this organization. Financial SCAN includes a detailed financial health analysis and peer comparison and benchmarking tool. Learn More

Financial SCAN

Financial SCAN

Key Financial SCAN Features

  • Financial Health Dashboard: Highlights key financial trends and ratios for a selected nonprofit organization over a period of up to five years.
  • Peer Comparison Dashboard: Compares the organization's financials with up to five peer nonprofits that you select.
  • Graphical Analysis: Provides multi-year graphs and an interpretive guide in a format ready to present to your clients.
  • Printable PDF Report: Provides a complete analysis of the organization for your records. The full report tells you what to look for and why it matters.
  • Advanced Search: Allows you to search by EIN (Employer Identification Number), organization name, city, state, revenue, expenses, and assets.


Forms 990 Provided by the Nonprofit

Sign in or create an account to view Form(s) 990 for 2012.


Financial Statements

Financial Statements for 2012, 2011, 2010 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Annual Reports

Sign in or create an account to view this information.



Leadership (GuideStar ExchangeThe GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more. January, 2014)

Mrs. Wendy K.D. Selig

Profile:

Wendy K.D. Selig is president and CEO of the Melanoma Research Alliance (MRA), a public charity focused on finding and funding the most promising melanoma research worldwide that will accelerate progress toward a cure. Selig drives and manages MRA's strategic priorities, research portfolio, and day-to-day operations.   Prior to joining the MRA, Selig spent nearly a decade in leadership positions at the American Cancer Society (the Society) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), recently, as ACS CAN's vice president of external affairs & strategic alliances, where she built strategic partnerships with corporations, foundations, trade associations, and federal agencies. She oversaw the Society's campaign to ensure access to quality healthcare and chaired United for Medical Research focused on sustained federal support for biomedical research funding at the NIH. In 2008, Selig was appointed to serve on the National Cancer Institute Director's Consumer Liaison GrouSelig served on Capitol Hill as a top aide for U.S. Representative Porter J. Goss (R-FL), the House Rules Committee, and the House Permanent Select Committee on Intelligence.A native of Princeton, NJ, Selig is a magna cum laude graduate of Princeton University and holds a Master in Science (with distinction) from Northwestern University's Medill School of Journalism.



Officers for Fiscal Year (IRS Form 990)

Report Added To Cart Officers for 2011, 2010, 2009, 2008 are included in the GuideStar Premium Report. Upgrade Now


Highest Paid Employees & Their Compensation (IRS Form 990)

Highest Paid Employee Data for 2011 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart


Program: Melanoma Research Funding

Budget:
$10,800,000
Category:
Skin Diseases
Population Served:
General Public/Unspecified
None
None

Program Description:

The MRA is focused on finding and funding the most promising melanoma research worldwide that will accelerate progress toward a cure. To date, MRA has awarded $48 million to 116 research programs to make transforming advances in the prevention, diagnosis and staging, and treatment of melanoma, including research in biological causes of carcinogenesis, skin screening, biomarkers, imaging, immunotherapy, molecularly targeted therapy, and combination therapy. MRA supports both individual investigator and collaborative team projects focused on translational, innovative research that will impact the prevention, diagnosis, staging, and treatment of melanoma in the near and intermediate future. The 2013-2014 Request for Proposals includes more detail about current funding opportunities. Young Investigator Awards aim to attract early career scientists with novel ideas into melanoma research, thereby recruiting and supporting the next generation of melanoma researchers. Young Investigators are scientists within four years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required. Pilot Awards test potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues. Established Investigator Awards support senior investigators with an established record of scientific productivity and accomplishment and who are past the initial four years of their first academic faculty appointment. Team Science Award Programs are the centerpiece of the MRA research funding portfolio. This program fulfills one of MRA’s primary goals: to foster a collaborative research process. Multidisciplinary teams consist of Principal Investigators with complementary expertise who may be from the same institution, inter-institutional, and/or international institutions. Team science projects promote transformational melanoma research advances with the potential for rapid clinical translation. Partnership Awards are designed to facilitate interactions between sectors including industry and other nonprofit organizations. Development Awards are a subtype of a Pilot Award in which one year of funding is provided to test potentially transformative "high-risk, high-reward" ideas that do not have extensive preliminary data but would establish proof-of-concept. Investigators who are past the initial four years of their first academic faculty are eligible.

Program Long-Term Success:

Program Short-Term Success:

In just a few years of active research, significant progress has already been made. The productivity of funded investigators as a direct result of MRA awards has been high, as measured in tangible outcomes and in promising early research results. MRA is building a robust, collaborative melanoma research community focused on delivering effective results as quickly as possible.

Program Success Monitored by:

All proposals undergo rigorous peer review by the MRA Grant Review Committee, comprised of experts in diverse areas of translational cancer research. The GRC operates under guidelines that ensure objective review by the committee. Of note, GRC members who are Principal Investigators on applications do not participate in the review of any applications. Members who have other conflicts with specific proposals may not review or vote on such proposals. Final funding decisions are ratified by the MRA Board of Directors. Full-term funding is contingent upon review of annual progress reports and other oversight activities conducted by MRA.

Program Success Examples:

More than $46 million in additional research funding leveraged from other sources by MRA investigators. The majority of this funding was granted by two sources: U.S. National Institutes of Health and other foundations. 18 clinical trials supported by MRA to test promising agents alone and in combination for the treatment of metastatic melanoma. 17 patent applications filed for new technology, which have the potential to be developed into new tools or treatments for patients. More than 100 papers published in high-impact journals describing research results supported by MRA, which inform the scientific and clinical communities about promising new research so that others may build upon the results to help patients. More than 145 collaborations initiated and strengthened between academic, government, and industry scientists, which enhance sharing of information and fast-forwarding of the research. Approximately 450 presentations delivered by MRA investigators at medical and scientific meetings around the world, where research results are shared and the profile of MRA is enhanced.

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium